BTIG on United Therapeutics Corp. (UTHR): 'we would love to see data post-launch on the cadence of adoption, both in PAH and PH-ILD'
Tweet Send to a Friend
BTIG analyst Julian Harrison reiterated a Neutral rating on United Therapeutics Corp. (NASDAQ: UTHR).The analyst comments "3Q25 was another quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
